Covalon Technologies Ltd. (COV) - Product Pipeline Analysis, 2014 Update - New Study Released

Covalon Technologies Ltd. (Covalon) is a healthcare service provider. The company research, develops and commercializes medical devices and healthcare technologies. It uses science and technology to solve medical challenges associated with prevention, detection and management areas such as infection, tissue repair, medical device biocompatibility, and condition management. Covalon's wound care products include ColActive plus Ag, ColActive transfer, CovaStat bioactive absorbable hemostatic sponge, and CovaSorb bioactive absorbent foam replacement dressing. The company also develops and commercializes proprietary technologies in the areas of advanced wound care, cardiology, urology, vascular access, orthopaedics and surgery. It works with medical device companies and medical distributors. Covalon is headquartered in Mississauga, Ontario, Canada.

Full Report Details at
- http://www.fastmr.com/prod/853023_covalon_technologies_ltd_cov_product_pipeline.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Covalon Technologies Ltd.
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies
* Develop market-entry and market expansion strategies
* Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
* Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Covidien plc (COV) - Product Pipeline Analysis, 2014 Update
- Qiagen N.V. (QIA) - Product Pipeline Analysis, 2014 Update
- GE Healthcare - Product Pipeline Analysis, 2014 Update
- Edwards Lifesciences Corporation (EW) - Product Pipeline Analysis, 2014 Update
- C. R. Bard, Inc. (BCR) - Product Pipeline Analysis, 2014 Update